Next quarterly earnings for Q4 2026 are scheduled to be reported around September 22, 2026, with analysts forecasting EPS of approximately $31.39 scheduled. Medium importance estimated as earnings releases typically cause significant price volatility.
Akros U.S. Tech 100 Protective Allocation Monthly Index
Exposure to 100 leading U.S. technology companies with systematic downside protection.
Recent events
Quarterly dividend of $0.47 per share, with an ex-dividend date of September 15, 2026, scheduled.
Fiscal Q3 2026 earnings release, with revenue guided between $2.41 billion and $2.46 billion and non-GAAP EPS between $3.63 and $3.69, is scheduled. Low impact is expected.
Quarterly cash dividend of $0.92 per share announced, with the ex-dividend date set for September 3, 2026; Low importance is estimated as quarterly dividends are regular events with minimal price impact, scheduled.
Importance is estimated as Medium due to the company's high-growth trajectory and significant investor focus on AI-related demand; the first quarter fiscal year 2027 earnings release on September 2, 2026, is scheduled.
Q2 FY2027 earnings release and conference call scheduled.
Medtronic announced it will report its first quarter fiscal year 2027 financial results on September 1, 2026. This is projected to have a Low impact of at least 1% as it is a routine announcement, scheduled.
NVIDIA's Q2 FY27 financial results and conference call are scheduled. High importance is estimated due to the significant market impact typically associated with the company's earnings reports.
High importance estimated as quarterly results often trigger >10% price movement; Q2 FY2027 earnings release on 2026-08-26 is scheduled.
Next quarterly earnings for fiscal Q4 2026 are scheduled to be released. The company projects revenue of approximately $3.35 billion. This earnings guidance is estimated to have a price impact of at least 5% scheduled
Q4 2026 earnings release and full fiscal year results scheduled.
Quarterly dividend with an ex-dividend date of August 20, 2026. The dividend of $0.91 per share is payable on September 10, 2026, to shareholders of record on August 20, 2026.
Fiscal Q3 2026 earnings report on August 19, 2026 expected, based on historical reporting schedules. Medium importance is estimated as earnings releases typically drive significant price movement.
Fiscal Q3 2026 earnings release is scheduled. Earnings releases are typically high-impact events with potential price movement ≥10%.
The ex-dividend date is 2026-08-14 for a quarterly dividend of $1.38 per share. The dividend is payable on 2026-09-10 to shareholders of record on 2026-08-17. A low price impact is estimated as this is a routine distribution and the event is scheduled.
Q3 2026 earnings release and conference call scheduled.
Q4 2026 earnings release and conference call scheduled for August 12, 2026. High importance due to potential for significant price volatility following the report, with analysts' EPS forecast of $1.13-$1.17 estimated.
Lumentum is scheduled to release its fiscal fourth quarter and full year 2026 financial results after the market closes on August 11, 2026. High importance is estimated as earnings releases often lead to >10% price impact, scheduled.
Q2 2026 earnings results and conference call, with market reaction expected to be neutral until the actual release as the date announcement typically has minimal impact, scheduled.
Q1 2027 earnings release; company guided for EPS between $0.670 and $0.710, while analysts forecast around $0.70. Estimated to have a medium impact based on historical earnings volatility scheduled
Q2 2026 earnings release and conference call scheduled.
Q2 2026 earnings report and conference call scheduled for August 5, 2026. Analysts forecast EPS of approximately $3.72-$3.76. High importance is estimated based on the historical price volatility associated with the company's earnings releases, scheduled.
Shopify announced on July 8, 2026, that it will release its second-quarter 2026 financial results before markets open on August 5, 2026, scheduled.
Fiscal Q3 2026 earnings release is scheduled for 2026-08-05. Analysts forecast an adjusted EPS of approximately $3.37-$3.38. A low price impact is estimated as the market typically waits for actual results and the event is scheduled.
Astera Labs is scheduled to release its Q2 2026 financial results after the market close on August 4, 2026, with a conference call to follow. Company guidance projects revenue between $355 million and $365 million. High importance is estimated due to the significant revenue guidance provided. This event is scheduled.
AMD will report fiscal second quarter 2026 financial results on August 4, 2026, after the market close. Analysts forecast significant year-over-year growth in EPS. High importance estimated due to historical earnings volatility, scheduled.
Caterpillar Q2 2026 earnings release scheduled for August 4, 2026; analysts forecast an EPS of approximately $6.17-$6.25. High importance is estimated due to the significant impact earnings reports typically have on the stock price, which is estimated.
Amgen is scheduled to report its Q2 2026 financial results after the market closes on August 4, 2026; analysts forecast an EPS of approximately $5.57-$5.60. This event is assigned Medium importance as earnings reports typically cause price shifts of 5% or more scheduled.
Arista Networks is scheduled to release its Q2 2026 financial results after market close on August 4, 2026; a price impact of at least 5% is estimated based on historical volatility scheduled
Merck to release its second-quarter 2026 financial results on August 4, 2026, before the market opens; low impact expected.
Q2 2026 earnings release scheduled for 2026-08-03. A price impact of ≥10% is estimated due to high valuation and focus on growth, scheduled.
Apple scheduled its Q3 2026 earnings release for July 30, 2026. Analysts forecast EPS of $1.88, a 19.8% YoY increase, and the company has guided for revenue growth between 14% and 17% YoY. This event is scheduled.
Alnylam is scheduled to report its second quarter 2026 financial results on July 30, 2026, before market open; high importance is assigned due to the potential for price impact exceeding 10% scheduled
Amazon to report its Q2 2026 financial results after market close on July 30, 2026, scheduled.
Q2 2026 earnings results to be reported after market close on July 30, 2026, scheduled. High importance is estimated due to the potential for a price impact of 10% or more following the announcement.
Roblox Q2 2026 earnings release is scheduled. Analysts forecast an EPS of approximately -$0.34 forecasted. Market reaction is expected to be significant as earnings typically drive price volatility.
Fortinet is scheduled to announce its second quarter 2026 financial results after the market closes on July 29, 2026. Analysts forecast EPS of $0.66. High importance is estimated as earnings typically drive significant price movement. This is scheduled.
Lam Research Q4 2026 earnings release on July 29, 2026, with analysts forecast of $1.68 EPS; high importance estimated due to typical >10% price impact scheduled.
Meta Platforms is scheduled to release its Q2 2026 financial results after market close on July 29, 2026, followed by a conference call. Analysts forecast EPS of $7.18 and revenue of $60.22B, which would be a significant increase from the previous year, with investor focus on AI monetization strategies. This event is scheduled.
Microsoft is scheduled to report its fourth quarter and full fiscal year 2026 financial results after market close on July 29, 2026. Analysts forecast adjusted EPS of $4.24 on revenue of $87.67B, which would be a significant increase from the prior year. High importance is estimated based on typical price volatility for major tech earnings. This event is scheduled.
Fourth quarter and full-year fiscal 2026 earnings results are scheduled to be released before the market opens on July 29, 2026. A significant market reaction is possible, as the previous earnings report on April 29, 2026, was followed by an 8% stock price increase, scheduled.
Biogen is scheduled to report its Q2 2026 financial results on July 29, 2026, before the market opens, followed by a conference call; a medium impact is estimated based on historical earnings volatility, expected.
Q1 FY2027 earnings release scheduled for July 29, 2026; analysts forecast EPS of approximately $0.81, forecasted.
Qualcomm is scheduled to release its Q3 fiscal 2026 earnings results on July 29, 2026, after market close; Medium importance is estimated as earnings guidance typically drives significant market volatility, scheduled.
Boeing is scheduled to release its Q2 2026 financial results on July 28, 2026. Analysts forecast a loss per share of -$0.24, an improvement from the prior year. The event is scheduled.
Q2 2026 earnings release scheduled. TD Cowen analysts forecast revenue of $837 million and adjusted EBITDA of $127 million. High importance estimated due to potential for significant volatility following recent project delays and short-seller allegations, scheduled.
Corning is scheduled to release its Q2 2026 financial results on July 28, 2026. The company has provided guidance for core sales of approximately $4.6 billion and core EPS between $0.73 and $0.77. This release is highly anticipated, especially after JPMorgan placed the stock on a 'Negative Catalyst Watch' on July 16, 2026, scheduled.
KLA Corporation to announce Q4 fiscal year 2026 earnings on July 28, 2026, scheduled
Teradyne is scheduled to release its financial results for the second quarter of 2026 after the market closes on July 28, 2026. A conference call is scheduled for the following morning. This is a recurring, significant event for investors, scheduled.
Cadence is scheduled to report its Q2 2026 financial results after the market closes on July 27, 2026. Analysts forecast EPS of approximately $2.05 on revenue of $1.57 billion. High importance is estimated due to the significant impact earnings reports typically have on technology stock volatility, scheduled.
Q2 2026 earnings release for Honeywell Technologies scheduled. This is the first report post-spin-off, with analysts forecasting EPS around $1.80-$1.81, a significant drop reflecting the new company structure. High importance is estimated due to potential high volatility from the first post-spin-off results scheduled.
Intel is scheduled to report its Q2 2026 financial results after the market close on July 23, 2026; analysts forecast revenue of approximately $14.4 billion and EPS of $0.21. High importance is estimated as earnings reports for major semiconductor firms often trigger ≥10% price movement, scheduled.
RTX Q2 2026 earnings results and conference call scheduled. High importance is assigned as earnings releases are major market catalysts; scheduled.
Q2 2026 earnings results are scheduled to be released before the market opens on July 23, 2026. Analysts forecast EPS of approximately $5.71 on revenue of $11.70 billion, forecasted.
Alphabet is scheduled to report its second-quarter (Q2) 2026 financial results on July 22, 2026, after the market close. High importance is estimated due to the potential for a 10% price impact from the earnings surprise scheduled
Full Q2 2026 results and investor conference call on July 22, 2026. High importance for the guidance update is estimated following the 20% preliminary drop, scheduled.
ServiceNow is scheduled to release its financial results for the second quarter of 2026 after the market closes on July 22, 2026; high importance is estimated due to expected price impact exceeding 10% scheduled.
Tesla is scheduled to report its financial results for the second quarter of 2026 on July 22, 2026, after the market closes. Analysts forecast EPS between $0.36 and $0.54, focusing on automotive gross margins. High importance is assigned as Tesla earnings typically result in >10% price volatility. This event is scheduled.
Q2 2026 earnings results and conference call scheduled. Analysts forecast EPS around $1.91 on revenue of $5.23 billion forecasted. Neutral impact expected as the market awaits actual performance against these estimates, scheduled.
Battlefield 6 Season 4 launches on July 21, 2026, introducing major new content including naval warfare, a new map, and a crossover event with the Top Gun franchise, scheduled.
On July 20, 2026, AMD announced the launch of its first rack-level AI system, Helios, and an expanded strategic partnership with Microsoft to deploy systems on Azure. High importance estimated due to the strategic impact of AI infrastructure news.
Effective July 20, 2026, the FAA restored Boeing's authority to self-certify the airworthiness of all new 737 MAX and 787 aircraft, ending years of direct FAA oversight following safety and quality issues.
S&P Global downgraded Oracle's long-term credit rating to BBB-, citing risks from its aggressive AI-related capital spending plan which has led to negative free cash flow.
Stock declined ~7% after a TD Cowen analyst note highlighted meaningful delays at two major data center projects (Oracle and AEP), posing potential risk to 2027-2028 revenue estimates.
Announced at the Farnborough International Airshow on July 20, 2026, the successful completion of the world's first high-altitude flight (above 30,000 feet) using a megawatt-class hybrid electric propulsion system, in partnership with NASA, Boeing, and BETA Technologies. This major technological milestone is estimated to have a ≥5% price impact, expected.
On July 20, 2026, Intel reported a new round of layoffs targeting its data center group (DCG) to improve efficiency; medium importance estimated as large-scale restructuring typically impacts stock price by ≥5%.
Barclays analyst Tom O'Malley upgraded Lumentum stock to 'Overweight' from 'Equal Weight' and maintained a $1,000 price target on July 20, 2026, citing rapidly improving profitability metrics; the stock gained over 9%.
On July 20, 2026, reports emerged that Meta is in talks to lease up to $10 billion in AI compute capacity to Anthropic and has hired former AWS executive Dave Brown to lead its new cloud compute division, signaling a major strategic push to monetize its AI infrastructure.
Wells Fargo analysts lowered the price target on MCHP stock from $95.00 to $88.00, maintaining an "equal weight" rating forecasted
On July 20, 2026, Meta faced a court case in Tennessee concerning allegations that it knowingly designed Instagram to be addictive for adolescents, highlighting ongoing legal and regulatory risks related to the platform's impact on teen mental health.
Raytheon division received a $1.81 billion contract modification from the U.S. Navy for the production of the AN/SPY-6(V) Family of Radars, with a potential total value of $3.39 billion if all options are exercised.
Pratt & Whitney Canada unit was awarded a nine-year, $1 billion contract to overhaul more than 750 engines for the U.S. military's T-6 trainer aircraft fleet.
On July 20, 2026, RBC Capital Markets maintained its "Outperform" rating and a $170 price target on Shopify, citing data indicating strong momentum for Q2 forecasted.
Netflix disclosed the $587 million cash acquisition of AI filmmaking startup InterPositive in its quarterly filing on 2026-07-19; the strategic move's market impact is estimated at 5%.
Stock fell approximately 9-10% on July 17, 2026, amid investor concerns that general-purpose AI agents could disrupt the specialized electronic design automation (EDA) software market, potentially eroding future pricing power.
Completed the acquisition of Johnson Matthey's Catalyst Technologies business for £1.325 billion in an all-cash transaction on July 17, 2026, strengthening its portfolio in refining, petrochemicals, and renewable fuels.
Awarded a contract by the U.S. Space Force for the National Security Space Launch (NSSL) Phase 3 Lane 1 program, announced on July 17, 2026.
Announced a senior secured debt facility of approximately $775 million to accelerate the global build-out of its AI cloud platform; medium importance estimated as this provides significant expansion capital.
Reported Q2 2026 earnings with adjusted EPS of $1.31, beating estimates of ~$1.28. Revenue was ~$12.5 billion, slightly missing estimates. The company raised its full-year 2026 adjusted EPS guidance to $5.45-$5.60. The stock rose over 11% in pre-market trading.
GE Aerospace reported Q2 2026 earnings on July 16, 2026, with earnings per share of $2.02 and revenue of $12.63 billion, beating analyst estimates of $1.86 and $11.87 billion, respectively. The company also raised its full-year 2026 guidance. This significant earnings beat and guidance raise is estimated to have a ≥10% price impact, expected.
The U.S. FDA approved Lipfendra (enlicitide) on July 16, 2026, as the first once-daily oral PCSK9 inhibitor; high impact expected due to first-in-class status.
Stock price fell approximately 14% amid a broader tech sell-off and continued investor concern over reports that major customer Meta Platforms intends to launch its own competing cloud infrastructure business.
Stock price fell over 11% on July 16, 2026, amid broader space-sector pressure and a new 'Neutral' rating from Piper Sandler.
Announced a definitive agreement to acquire the intellectual property and source code of XM Cyber, a leader in attack path management, as part of an expanded partnership with Schwarz Digits.
On July 16, 2026, the US CISA added two critical Fortinet FortiSandbox vulnerabilities to its Known Exploited Vulnerabilities (KEV) catalog, indicating active exploitation in the wild.
On July 16, 2026, Intel and Google Cloud announced an expanded partnership to integrate Google's Gemini Enterprise AI across Intel's global workforce; medium importance estimated as strategic AI partnerships often result in ≥5% price impact.
Intuitive Surgical reported Q2 2026 financial results, with revenue of $2.89 billion and non-GAAP EPS of $2.80, both beating analyst estimates. Despite the beat, the stock price fell over 9% in after-hours trading.
The company disclosed on its Q2 earnings call that it has submitted a 510(k) application to the FDA for a new flexible robotic endoscope for gastrointestinal (GI) tract procedures.
Medtronic announced on July 16, 2026, that it has completed its $650 million acquisition of SPR Therapeutics, a company specializing in peripheral nerve stimulation (PNS) for pain management. This is projected to have a Medium impact of at least 5% due to the strategic expansion.
Netflix reported Q2 2026 earnings on 2026-07-16 with EPS of $0.80 and revenue of $12.56 billion; weak Q3 guidance led to an 8% stock price decline.
Announced 'Build' on 2026-07-16, a new mobile-first creation tool using AI to allow users to create games from text prompts directly within the Roblox app. Public alpha testing is scheduled to begin on July 28, 2026 scheduled. AI-driven product innovation is expected to drive positive sentiment.
Board of directors declared a quarterly cash dividend of $1.42 per share on 2026-07-16, payable on August 11, 2026.
On July 15, 2026, CEO Gregory Smith and Director Marilyn Matz sold a combined total of over $1.8 million in company stock. This was part of a larger trend of insider sales totaling approximately $14.86 million over the preceding 90 days with no reported insider buying. This significant insider activity is estimated to have a high market impact.
Johnson & Johnson reported Q2 2026 earnings on 2026-07-15, with revenue of $25.3 billion and adjusted EPS of $2.90, beating analyst expectations and raising full-year guidance.
On July 15, 2026, Alnylam presented progress on its neuroscience programs at the Alzheimer's Association International Conference (AAIC) 2026, including updates on studies for Alzheimer's disease and related disorders.
Biogen announced the appointment of Michael J. Parini as Chief Legal Officer, effective August 3, 2026.
Appointed AJ Shipley as the new Chief Product Officer (CPO).
IBM issued preliminary Q2 2026 results on July 14, 2026, missing revenue ($17.2B vs ~$17.86B expected) and EPS ($2.93 vs ~$3.01 expected) estimates due to Infrastructure segment weakness, causing a >20% stock drop.
Announced a multi-year agreement with AI startup Reflection, valued at over $1 billion, to provide AI compute capacity through 2029; high importance estimated due to the contract's massive scale relative to annual revenue.
Boeing announced on July 14, 2026, that it delivered 64 commercial airplanes in June, bringing its second-quarter total to 171, viewed as a positive indicator for financial performance.
Biogen presented detailed Phase 2 data for its Alzheimer's drug diranersen, which missed its primary endpoint but showed a 26% slowing of cognitive decline at its lowest dose. The stock fell over 8% following the news.
Merck's partner Kelun-Biotech announced on July 14, 2026, that a Phase 3 trial of sac-TMT with KEYTRUDA met its primary endpoint; medium impact expected as it strengthens the oncology pipeline.